These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10624564)

  • 21. The US drug safety system: role of the pharmaceutical industry.
    Gibson BR; Suh R; Tilson H
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):110-4. PubMed ID: 17724741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Handing over the baton: connecting medicinal chemistry with process R&D.
    Federsel HJ
    Drug News Perspect; 2008 May; 21(4):193-9. PubMed ID: 18560618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outsourcing lead optimisation--the quiet revolution.
    Clark DE; Newton CG
    Drug Discov Today; 2004 Jun; 9(11):492-500. PubMed ID: 15149625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The difficulties industry is facing with investigators.
    Blackledge GR
    Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An audience with...Joseph Bolen. Interview by Bethan Hughes.
    Bolen J
    Nat Rev Drug Discov; 2009 Aug; 8(8):608. PubMed ID: 19644470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving drug discovery output--starting with the early discovery enterprise.
    Sofia MJ
    Drug Discov Today; 2004 Apr; 9(7):293-5. PubMed ID: 15037225
    [No Abstract]   [Full Text] [Related]  

  • 27. The epiphany of data warehousing technologies in the pharmaceutical industry.
    Barrett JS; Koprowski SP
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):S3-13. PubMed ID: 11911607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug discovery chemistry: a primer for the non-specialist.
    Jordan AM; Roughley SD
    Drug Discov Today; 2009 Aug; 14(15-16):731-44. PubMed ID: 19416759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No immediate pain relief for the pharmaceutical industry.
    Ahlborn H; Henderson S; Davies N
    Curr Opin Drug Discov Devel; 2005 May; 8(3):384-91. PubMed ID: 15892254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translational research in the pharmaceutical industry: from theory to reality.
    Sultana SR; Roblin D; O'Connell D
    Drug Discov Today; 2007 May; 12(9-10):419-25. PubMed ID: 17467579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceutical marketing in a new age. Effective campaigns still need to focus on what customers want.
    Rao SK
    Mark Health Serv; 2002; 22(1):6-12. PubMed ID: 11881547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.
    McFadden DW; Calvario E; Graves C
    J Surg Res; 2007 Jun; 140(1):1-5. PubMed ID: 17481979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
    Fortunak J; Confalone PN; Grosso JA
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
    [No Abstract]   [Full Text] [Related]  

  • 35. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics.
    Posner BA
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):487-94. PubMed ID: 16022185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug development for children: how is pharma tackling an unmet need?
    Hawcutt DB; Smyth RL
    IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hit-to-lead process at Schering AG: strategic aspects.
    Steinmeyer A
    ChemMedChem; 2006 Jan; 1(1):31-6. PubMed ID: 16892330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
    Shumoogam J; Al-Shamahi A
    IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines for minor use and minor species (MUMS)--industry's views.
    Bönisch B
    Dev Biol (Basel); 2004; 117():105-10. PubMed ID: 15597625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.